Using statins for the primary prevention of VTE may slightly reduce the incidence of VTE and all-cause mortality. However, this effect is likely too weak to be considered significant. Statin use may ...

A rare type of pulmonary hypertension (PH), CTEPH is caused by the formation of blood clots in the pulmonary arteries ...

Every day, countless individuals may experience symptoms linked to blood clots without realizing it. According to the Centers for Disease Control and Prevention (CDC), approximately 900,000 people in ...

PH is caused by blood clots (thromboemboli ... and other conditions. Pulmonary hypertension has no cure. Treatment aims to manage symptoms and prevent further lung damage. The approach depends on ...

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) recently awarded a $3.7 ...

Hundreds of people with multiple myeloma could receive a new, targeted treatment recommended for use within the Cancer Drugs Fund today (Tuesday, 29 October). More evidence is needed on the clinical ...

Lung cancer may be classified as metastatic upon the initial diagnosis or later on following treatment if the cancer suddenly spreads. If lung cancer spreads to the brain, for example, the new cancer ...

Your risk of forming blood clots is higher if you have PAH ... Pulmonary Hypertension Association: “About Pulmonary Hypertension,” “Treatments,” “Epoprostenol (Flolan).” ...

Pulmonary arterial hypertension (PAH ... These drugs can help prevent blood clots. The most common form is warfarin. Diuretics. These are "water pills" that help get rid of extra fluid in your ...

A new treatment combining ReCET and semaglutide eliminated insulin use in 86% of type 2 diabetes patients, improving natural insulin sensitivity. A new treatment combining ReCET and semaglutide could ...

For people with stroke, social factors such as race, neighborhood and insurance, may be linked to whether they receive treatment ... received clot-busting drugs and 5,951 people, or 4%, received ...